ArticleOncology letters2024

Efficacy and safety of TACE combined with tyrosine kinase inhibitors and camrelizumab for unresectable hepatocellular carcinoma: A systematic review and meta‑analysis.

Jiahui Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.